Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TH-302 and Bevacizumab in Recurrent High Grade Astrocytoma
NCT01403610Phase 2Completed
- Sponsor
- UT Health San Antonio
- Start
- Jun 2011
- Primary completion
- Oct 2015
- Countries
- 1
01
Overview
A Phase 2 trial of evofosfamide in high-grade glioma (HGG), sponsored by UT Health San Antonio. Started Jun 2011; status: completed.
02
Drugs
evofosfamide
03
Conditions
high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT01403610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01403610.